Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice.
about
Renal endothelial dysfunction in diabetic nephropathyMaintenance of endothelial guanosine triphosphate cyclohydrolase I ameliorates diabetic nephropathy.Vascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db miceMethylglyoxal modulates endothelial nitric oxide synthase-associated functions in EA.hy926 endothelial cellsPodocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice.New targets for treatment of diabetic nephropathy: what we have learned from animal models.A novel mouse model of advanced diabetic kidney disease.Endothelial nitric oxide synthase (eNOS) 4b/a polymorphism and the risk of diabetic nephropathy in type 2 diabetes mellitus: A meta-analysis.Reduced Krüppel-like factor 2 expression may aggravate the endothelial injury of diabetic nephropathy.Biopterin metabolism and eNOS expression during hypoxic pulmonary hypertension in mice.Diffuse glomerular nodular lesions in diabetic pigs carrying a dominant-negative mutant hepatocyte nuclear factor 1-alpha, an inheritant diabetic gene in humans.Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathyDirect Observation of Enhanced Nitric Oxide in a Murine Model of Diabetic Nephropathy.Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy.Decreased levels of proapoptotic factors and increased key regulators of mitochondrial biogenesis constitute new potential beneficial features of long-lived growth hormone receptor gene-disrupted mice.Sestrin 2 and AMPK connect hyperglycemia to Nox4-dependent endothelial nitric oxide synthase uncoupling and matrix protein expression.Genetic Targeting of Arginase-II in Mouse Prevents Renal Oxidative Stress and Inflammation in Diet-Induced Obesity.Strategies to reverse endothelial dysfunction in diabetic nephropathyDiabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal InjuryNitric oxide in the normal kidney and in patients with diabetic nephropathy.Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications.Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.Enhancing eNOS activity with simultaneous inhibition of IKKβ restores vascular function in Ins2(Akita+/-) type-1 diabetic mice.Evaluation of inducible nitric oxide synthase inhibition on kidney function and structure in high-fat diet-induced kidney disease.Modelling diabetic nephropathy in mice.Glomerular Endothelial Cells Stress and Cross-Talk With Podocytes in the Development of Diabetic Kidney Disease.Growth differentiation factor 15 impairs aortic contractile and relaxing function through altered caveolar signaling of the endothelium.Effects of folic acid on renal endothelial function in patients with diabetic nephropathy: results from a randomized trial.Sepiapterin Improves Vascular Reactivity and Insulin-Stimulated Glucose in Wistar Rats
P2860
Q27021318-A4F2E872-10D2-498E-8FC3-3657BA3BE868Q30541115-E262E53D-17DC-40A1-9810-A4591DAAA112Q31159383-C0FABC85-EC68-4FD1-8054-AB716791C880Q33589250-AF547AC0-7C45-426C-8838-E336543FE479Q33974608-DCC828F6-66A0-4334-B50E-CF9D14096E69Q34498964-8001A7A6-EAC8-4673-B67E-2CB61C9D9B1BQ34712527-F292ABC8-12CD-4A55-8684-DA9DDF912574Q34878686-41FA87A6-32F6-4C22-9377-B25FB747DA89Q35033762-6DDD35CD-93F4-43E4-B188-5970FAA9E924Q35060939-50C783FF-1973-41E5-B4E0-2116D57F76D9Q35125191-81694CC7-CE8A-4992-8C50-B2D9001C74CEQ36017619-3D6DF73B-39E4-4A40-B0DC-A621499B63EFQ36253868-321FD670-CC06-4084-A2FD-B2F07C92889DQ36297539-291CD4BE-2E49-4806-9753-AA01C1FBB4E0Q36542481-711E7CBE-FC4C-4AEE-98A4-F5E3E76045E4Q37003167-5534A2A5-83C0-469B-8F81-E8E7E3C21372Q37122718-1E803BF4-2AF7-47B8-8E32-174E0AB3D921Q37428427-9B29E2CE-0BC9-4986-8BBA-6E37FB594362Q37557795-A4FF6833-B26C-4A74-A59D-B7963FE84EC3Q37597721-B9F00FA5-E8F0-4187-BD2E-D00F79A42A2EQ38248725-9E6B8365-A9A2-423B-B08A-855EDD30D4F2Q40322521-92B178C5-849B-4B02-A3E0-010E736C9B39Q42778066-8FCCFED6-1003-412B-B386-3ED9B591A9D6Q45878094-7AE3DE19-8520-4CCA-A62A-0289D3EC46BBQ46301293-8D38A89A-283A-4A51-A8CA-EB01B7FFFD63Q47735079-28EEA8A0-2807-46DB-9544-4E72573C0C34Q52599406-723A20D9-C4F6-4271-8867-7E54E68A6D23Q52632771-3419EF4D-04F9-4D1E-9DE9-0BDBE9B0725AQ53058371-A623DE5F-1EAD-4FC0-9BF4-67320BDD2844Q57821805-DCF8177D-2710-498B-8C46-50C76DE6C65F
P2860
Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Improvement of endothelial nit ...... tic nephropathy in db/db mice.
@en
Improvement of endothelial nit ...... tic nephropathy in db/db mice.
@nl
type
label
Improvement of endothelial nit ...... tic nephropathy in db/db mice.
@en
Improvement of endothelial nit ...... tic nephropathy in db/db mice.
@nl
prefLabel
Improvement of endothelial nit ...... tic nephropathy in db/db mice.
@en
Improvement of endothelial nit ...... tic nephropathy in db/db mice.
@nl
P2093
P2860
P356
P1433
P1476
Improvement of endothelial nit ...... tic nephropathy in db/db mice.
@en
P2093
Hanmin Wang
Huifang Cheng
Paisit Paueksakon
Raymond C Harris
Xiaofeng Fan
P2860
P2888
P304
P356
10.1038/KI.2012.248
P407
P577
2012-07-11T00:00:00Z
P5875
P6179
1011945226